Time-Efficient Strategies to Ensure Vaccine Risk/Benefit Communication
To access this article, please choose from the options below
PII: S0882-5963(05)00238-1
doi:10.1016/j.pedn.2005.06.012
© 2005 Published by Elsevier Inc.
PII: S0882-5963(05)00238-1
doi:10.1016/j.pedn.2005.06.012
© 2005 Published by Elsevier Inc.